// App-Quantinova.ai

3060 : PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.

Researchers

Presenter

  • Tahlia Scheinberg

Principal Investigators

  • Anna Lomax

  • Martin HN Tattersall

  • David Morgan Thomas

  • Geoffrey Brian McCowage

  • Michael James Sullivan

  • Vivek Bhadri

Medical Centers

  • Chris O'Brien Lifehouse, Camperdown, Australia

  • The University of Sydney, Camperdown, Australia

  • Garvan Institute of Medical Research, Darlinghurst, Australia.

  • The Children's Hospital at Westmead, Westmead, Australia

  • Royal Children's Hospital, Melbourne, Victoria, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved